0
shop
  • Home
  • Voyageur Pharmaceuticals Announces IRR of 137% & NPV of $344 Million from Preliminary Economic Assessment for the Frances Creek Pharmaceutical Barium Project

PEA News Jan 11 2021 (1)



Recent Posts

Voyageurs JV Partner Continues to Advance Utah Lithium Project

Voyageur to Manufacture Barium Pharmaceuticals with Joint Venture

Voyageur Summer Summary

Corporate Presentation

download our presentation

join our mailing list

Sign-up to receive our company and industry news by e-mail.